CMS PICKING WINNERS IN WOUND CARE?
Steve Gruber reports new evidence a CMS pricing rule could shutter smaller U.S. skin-substitute makers while select firms get reimbursements “16 times what the government allows other manufacturers to charge.”
Steve Gruber reports new evidence a CMS pricing rule could shutter smaller U.S. skin-substitute makers while select firms get reimbursements “16 times what the government allows other manufacturers to charge.”